Streetbeat News

VGZ

Vista Gold Corp.

https://www.vistagold.com

Industry

Gold

Vista Gold Corp., together with its subsidiaries, engages in the evaluation, acquisition, exploration, and advancement of gold exploration and development projects primarily in Australia. The company's flagship asset is the Mt Todd gold project located in Northern Territory. Vista Gold Corp. was founded in 1983 and is headquartered in Littleton, Colorado.

Open

0.76

Mkt cap

95M

Volume

383K

High

0.79

P/E Ratio

8.49

52-wk high

0.83

Low

0.76

Div yield

N/A

52-wk low

0.45

Vista Gold (AMEX:VGZ) reported a significant improvement in its Q2 earnings, with EPS rising to $0.13 from a loss of $(0.01) per share year-over-year, marking a 1400% increase.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 9:18 pm

HC Wainwright & Co. has maintained a Buy rating on Vista Gold (AMEX:VGZ) and raised the price target from $2.5 to $2.75.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 10:06 am

Vista Gold Corp. has received a $10 million final installment payment from Wheaton Precious Metals under a royalty agreement related to Vista's Mt Todd Gold Project in Northern Territory, Australia.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 10:51 am

Gold prices surged to over $2,200 per ounce, influenced by the Federal Reserve's indication of interest rate cuts, leading to a 30% rally in several gold mining stocks. Bank of America analysts favor gold as a trade for 2024, citing its hedge status, central bank accumulations, and potential ETF investor increases. Despite gold's rise, some mining stocks like the VanEck Gold Miners ETF (GDX) lag behind. Bank of America identifies undervalued stocks such as Centerra Gold Inc. (CGAU), B2Gold Corp. (BTG), Barrick Gold Corp. (GOLD), and Newmont Corp. (NEM), recommending stocks with high upside beta ratios.

Portfolio Pulse from Piero Cingari

March 22, 2024 | 3:56 pm

Insiders at Vista Gold, Retractable Technologies, and Fresh Tracks Therapeutics have recently made notable purchases of their companies' stocks. Vista Gold's CFO bought shares at $0.48 each, while Retractable Technologies' CEO acquired shares at $1.19 each. Fresh Tracks Therapeutics saw a purchase by a 10% owner at $0.91 per share. These transactions may signal insider confidence despite Vista Gold and Retractable Technologies reporting losses and Fresh Tracks Therapeutics discontinuing operations.

Portfolio Pulse from Avi Kapoor

March 22, 2024 | 12:58 pm

HC Wainwright & Co. analyst Heiko Ihle has reiterated a Buy rating on Vista Gold (AMEX:VGZ) and maintained a $2.5 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 1:22 pm

Vista Gold (AMEX:VGZ) reported a Q4 EPS of $(0.01), consistent with the previous year's results. The company has shown no revenue for the entire year, with a net loss fluctuating each quarter but remaining in the negative.

Portfolio Pulse from Happy Mohamed

March 14, 2024 | 9:10 pm

Gold and silver prices surged to new highs following Fed Chair Jerome Powell's hints at potential rate cuts in 2024, boosting mining stocks and ETFs. The SPDR Gold Trust (GLD) and Invesco DB USD Index Bullish Fund ETF (UUP) experienced significant movements, alongside a rally in mining stocks and ETFs like the VanEck Gold Miners ETF (GDX) and the VanEck Junior Gold Miners ETF (GDXJ).

Portfolio Pulse from Piero Cingari

March 06, 2024 | 5:43 pm

Insiders at four companies have recently made notable purchases of their own company's stock. Entera Bio Ltd. (ENTX) Director Haya Taitel bought shares at $0.77 each after the company received an extension from Nasdaq to regain compliance. OPKO Health, Inc. (OPK) 10% owner Frost Gamma Investments Trust purchased shares at $0.94 each following the pricing of a $200 million convertible notes offering. Fresh Tracks Therapeutics, Inc. (FRTX) 10% owner Exploration Capital LLC acquired shares at $0.98 each as the company plans a special meeting to seek approval of liquidation. Vista Gold Corp. (VGZ) Director Tracy Austin Stevenson bought shares at $0.37 each after the company announced a $20 million royalty agreement with Wheaton Precious Metals.

Portfolio Pulse from Avi Kapoor

January 12, 2024 | 12:48 pm

Insiders at four companies with stock prices under $3 have recently made notable purchases. Vivani Medical Director Gregg Williams bought shares at $0.88 each after the company reported a wider-than-expected quarterly loss. Amesite CEO Ann Marie Sastry purchased shares at $1.85 each, following a new partnership announcement with a community college. Vista Gold CFO Douglas L Tobler acquired shares at $0.45 each as the company announced a royalty agreement with Wheaton Precious Metals. BigBear.ai Director Pamela Braden bought shares at $1.92 each, coinciding with an expanded partnership with Amazon Web Services.

Portfolio Pulse from Avi Kapoor

December 22, 2023 | 11:30 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.